Could a common heart drug tame nosebleeds in a rare bleeding disorder?
NCT ID NCT04113187
First seen May 24, 2026 · Last updated May 24, 2026
Summary
This study looked at whether propranolol, a beta-blocker usually used for heart conditions, can help people with hereditary hemorrhagic telangiectasia (HHT) who have frequent nosebleeds. Fifteen adults with HHT took propranolol for three months. The main goal was to see if the total time spent nosebleeding each month went down. The study also tracked how often nosebleeds happened, changes in skin spots, blood levels, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEREDITARY HEMORRHAGIC TELANGIECTASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Bordeaux - service de médecine interne
Bordeaux, France
Conditions
Explore the condition pages connected to this study.